GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103) — StellaEarly Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations(1 site)
China
Tongji Hospital of Tongji Medical Colledge, Huazhong University of Science and Technology, Wuhan, Hubei Last updated September 2025